Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review by Nina Yu, Osama A Raslan, Han Sung Lee, Brett J Theeler, Tarek A Raafat, Ruben Fragoso, Kiarash Shahlaie, Orwa Aboud

Subjects: “…BRAF inhibitors…”
Get full text

Surrogate to predict overall survival in patients with BRAF V600E-mutant colorectal cancer treated with BRAF inhibitor combinations by J. Ros, V. Navarro, G. Villacampa, I. Baraibar, F. Salvà, M. Rodriguez, C. Vaghi, A. Garcia, A. Alcaraz, J. Tabernero, E. Élez, R. Dienstmann

Subjects: Get full text

Novel therapy: Combined BRAF and MEK inhibitors for locally advanced BRAF V600L–Positive mucosal melanoma in hypopharynx by Sivakamavalli Jeyachandran

Subjects: “…BRAF…”
Get full text

Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer by Eunyoung Tak, Hye-In An, Amy Sinyoung Lee, Kyuyoung Han, Jiwan Choi, Hyung-don Kim, Yong Sang Hong, Sun Young Kim, Eun Kyung Choi, Jeong Eun Kim, Tae Won Kim

Subjects: “…BRAF V600E…”
Get full text

The prevalence of BRAF V600E mutation in hairy cell leukemia: A systematic review and meta-analysis study by Mehrdad Payandeh, Masoud Sadeghi, Edris Sadeghi, Nasrin Iranshahi

Subjects: “…BRAF…”
Get full text

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure by Michael P Smith, Emily J Rowling, Zsofia Miskolczi, Jennifer Ferguson, Loredana Spoerri, Nikolas K Haass, Olivia Sloss, Sophie McEntegart, Imanol Arozarena, Alex von Kriegsheim, Javier Rodriguez, Holly Brunton, Jivko Kmarashev, Mitchell P Levesque, Reinhard Dummer, Dennie T Frederick, Miles C Andrews, Zachary A Cooper, Keith T Flaherty, Jennifer A Wargo, Claudia Wellbrock

Subjects: Get full text

Cross-method comparison for BRAF p.V600 mutation cfDNA testing in Melanoma: BRAFI study by Clara Mayo de las Casas, Eloisa Jantus-Lewintre, Sebastian Ortiz Reina, Ana Drozdowskyj, Pablo Cerezuela-Fuentes, Jose Luis Manzano, Pablo Ayala de Miguel, Ana Arance Fernandez, Miguel Angel Berciano-Guerrero, Almudena Garcia-Castaño, Teresa Puertolas, Guillermo Crespo, Maria Quindos-Varela, Juan Francisco Rodriguez-Moreno, Alfonso Berrocal, Eva Muñoz-Couselo, Enrique Espinosa, Joselyn Valarezo, Susana Muñoz, Silvia Calabuig-Fariñas, Miguel Angel Molina, Rafael Rosell, Joan Anton Puig-Butille, Maria Gonzalez-Cao

Subjects: Get full text

Lung Adenocarcinoma With Initially Co‐Occurring EGFR and BRAF Double Mutation: A Case Report and Literature Review by Lu Wang, Xueting Wang, Motong Xu, Yanan Wang, Lingxin Feng, Xue Yang, Jing Wang

Subjects: “…BRAF…”
Get full text

The combination of mutations in BRAF and NRAS genes within a one tumor in patients with cutaneous melanoma by M. B. Aksenenko, A. S. Averchuk, T. G. Ruksha

Subjects: Get full text

Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignancies by L. Weiss, D. Zhang, W.G. Kunz, S. Boeck, G. Curigliano, V. Subbiah, F. Lordick, T. Brummer, C.B. Westphalen, L. Boscolo Bielo

Subjects: Get full text

A compilation of 13 patients with metastatic colorectal cancer and concomitant BRAF and RAS family mutations by Jigisha Srivastav, Morgan E. Lehman, Joni K. Evans, Ravi Paluri, Caio Max Sao Pedro Rocha Lima

Subjects: Get full text

Resistance to BRAF inhibitors drives melanoma sensitivity to Chk1 inhibition by Danielle G. Carvalho, Juliana C.N. Kenski, Daniel A. Moreira, Matheus A. Rajão, Oscar Krijgsman, Carolina Furtado, Mariana Boroni, João P.B. Viola, Daniel S. Peeper, Patricia A. Possik

Subjects: Get full text

High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors by Ariane Fizazi, Chris Serrand, Alexandre Evrard, Blanche Bergeret, Pierre-Emmanuel Stoebner, Myriam Marque

Subjects: Get full text

Melanoma genomics – will we go beyond BRAF in clinics? by Justyna Mirek, Wiesław Bal, Magdalena Olbryt

Subjects: Get full text

Prospects of BRAF/MEK Inhibitor Therapy in Papillary Craniopharyngiomas with the BRAF V600E Mutation: A Scoping Review by Shingo FUJIO, Rafi ILMANSYAH, Ryutaro MAKINO, Tareq JURATLI, Jun SUGATA, Yuriz BAKHTIAR, Ryosuke HANAYA

Subjects: Get full text

Identifying a wide range of mutations in the <i>BRAF</i> gene for prescribing targeted drugs for melanoma treatment by A. N. Toropovskiy, A. G. Nikitin, A. V. Solov'ev, R. M. Khuzina, O. N. Pavlova

Subjects: Get full text

[Comment] Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE... by Zhang Rongxin

Subjects: Get full text

BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient by Maria Antonietta Castaldi, Nadia Petrillo, Carmine Selleri, Monica Ianniello, Anna Maria Della Corte, Eloisa Evangelista, Luigia De Falco, Roberto Sirica, Marika Casillo, Alessia Caleo, Alessandro Caputo, Pio Zeppa, Salvatore Giovanni Castaldi, Pasqualina Scala, Bianca Serio, Giovanni Savarese, Valentina Giudice

Subjects: Get full text

Metastatic Low‐Grade Glioma Successfully Treated in a Pediatric Patient With BRAF A598_T599insI Mutation by Pierluigi Calò, Safiatou Diallo, Laetitia Lebrun, Nathalie Gilis, Marco Preziosi, Pierre Leblond

Subjects: Get full text

THE ROLE OF BRAF V600E IN THE DEVELOPMENT OF THYROID CANCER PHENOTYPE: A SYSTEMATIC REVIEW by Pratia Mega, Aspitriani, Ika Kartika Edi Poedjo Purnamawati, Krisna Murti

Subjects: “…braf v600e…”
Get full text